Literature DB >> 20479279

Update on paraneoplastic neurologic disorders.

Myrna R Rosenfeld1, Josep Dalmau.   

Abstract

When patients with cancer develop neurologic symptoms, common causes include metastasis, infections, coagulopathy, metabolic or nutritional disturbances, and neurotoxicity from treatments. A thorough clinical history, temporal association with cancer therapies, and results of ancillary tests usually reveal one of these mechanisms as the etiology. When no etiology is identified, the diagnosis considered is often that of a paraneoplastic neurologic disorder (PND). With the recognition that PNDs are more frequent than previously thought, the availability of diagnostic tests, and the fact that, for some PNDs, treatment helps, PNDs should no longer be considered diagnostic zebras, and when appropriate should be included in the differential diagnosis early in the evaluation.

Entities:  

Mesh:

Year:  2010        PMID: 20479279      PMCID: PMC3227988          DOI: 10.1634/theoncologist.2010-0001

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  119 in total

1.  Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis.

Authors:  Fabián Bernal; Francesc Graus; Alex Pifarré; Albert Saiz; Baya Benyahia; Teresa Ribalta
Journal:  Acta Neuropathol       Date:  2002-01-31       Impact factor: 17.088

2.  Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.

Authors:  Bethan Lang; Ashwin Pinto; Federica Giovannini; John Newsom-Davis; Angela Vincent
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

3.  P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system.

Authors:  R Voltz; A F Carpentier; M R Rosenfeld; J B Posner; J Dalmau
Journal:  Muscle Nerve       Date:  1999-01       Impact factor: 3.217

4.  Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility.

Authors:  Roberto De Giorgio; Monica Bovara; Giovanni Barbara; Marco Canossa; Giovanni Sarnelli; Fabrizio De Ponti; Vincenzo Stanghellini; Marcello Tonini; Silvia Cappello; Eleonora Pagnotta; Eduardo Nobile-Orazio; Roberto Corinaldesi
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

5.  Paraneoplastic encephalitis associated with cystic teratoma is detected by fluorodeoxyglucose positron emission tomography with negative magnetic resonance image findings.

Authors:  Simin Dadparvar; Gregory S Anderson; Peeyush Bhargava; Liang Guan; Phillip Reich; Abass Alavi; Hongming Zhuang
Journal:  Clin Nucl Med       Date:  2003-11       Impact factor: 7.794

6.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Authors:  Setareh Shams'ili; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Herbert Hooijkaas; Bronno van der Holt; Charles Vecht; Peter Sillevis Smitt
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

7.  Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.

Authors:  Steven Vernino; Paul Tuite; Charles H Adler; James F Meschia; Bradley F Boeve; Peter Boasberg; Joseph E Parisi; Vanda A Lennon
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

Review 8.  Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature.

Authors:  Peter Widdess-Walsh; Jinny O Tavee; Stephan Schuele; Glen H Stevens
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

Review 9.  Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.

Authors:  Iñigo Rojas-Marcos; Audrey Rousseau; Florence Keime-Guibert; Ramón Reñé; Stéphanie Cartalat-Carel; Jean Yves Delattre; Francesc Graus
Journal:  Medicine (Baltimore)       Date:  2003-05       Impact factor: 1.889

10.  Voltage-gated potassium channel antibodies in limbic encephalitis.

Authors:  Patricia Pozo-Rosich; Linda Clover; Albert Saiz; Angela Vincent; Francesc Graus
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

View more
  3 in total

1.  Detection of underlying malignancy in patients with paraneoplastic neurological syndromes: comparison of 18F-FDG PET/CT and contrast-enhanced CT.

Authors:  N Schramm; A Rominger; C Schmidt; J N Morelli; C Schmid-Tannwald; F G Meinel; M F Reiser; C Rist
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-03-16       Impact factor: 9.236

2.  Subacute Cerebellar Degeneration due to a Paraneoplastic Phenomenon Associated with Metastatic Merkel Cell Carcinoma: A Case Report.

Authors:  Angelos Sharobeam; Jason Ray; Juliana Dong; Victor Chong
Journal:  Case Rep Oncol       Date:  2017-08-16

3.  Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasm.

Authors:  Michael Boch; Anja Rinke; Peter Rexin; Maria Seipelt; Dörte Brödje; Marvin Schober; Thomas M Gress; Patrick Michl; Sebastian Krug
Journal:  BMC Cancer       Date:  2014-09-22       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.